115 related articles for article (PubMed ID: 9157465)
1. In vitro alkylating of alpha, beta-unsaturated amidoesters, diethyl pyridylmethylphosphonates and their cis-Pt(II)complexes.
Najman-Bronzewska L; Ochocki J
Pharmazie; 1997 Mar; 52(3):198-202. PubMed ID: 9157465
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effect of Pt(II) amine phosphonate complexes on sarcoma sa-180 in mice. Crystal structure of cis-dichlorobis(diethyl-4-pyridylmethylphosphonate-kappaN)platinum(II) hydrate, cis-[PtCl2(4-pmpe)2].H20.
Aranowska K; Graczyk J; Checińska L; Pakulska W; Ochock J
Pharmazie; 2006 May; 61(5):457-60. PubMed ID: 16724546
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic activity and chemical reactivity of cis-platinum(II) and trans-palladium(II) complexes with diethyl (pyridinylmethyl)phosphates.
Kalinowska-Lis U; Szmigiero L; Studzian K; Ochocki J
Eur J Med Chem; 2009 Feb; 44(2):660-4. PubMed ID: 18586354
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K
Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.
Liu W; Chen X; Xie M; Lou L; Ye Q; Yu Y; Hou S
J Inorg Biochem; 2008 Oct; 102(10):1942-6. PubMed ID: 18707762
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, in vitro cytotoxic and antiviral activity of cis-[Pt(R(-) and S(+)-2-alpha-hydroxybenzylbenzimidazole)2Cl2] complexes.
Gökçe M; Utku S; Gür S; Ozkul A; Gümüş F
Eur J Med Chem; 2005 Feb; 40(2):135-41. PubMed ID: 15694648
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effectivity of two diaminocyclohexane Pt-complexes.
Balázová E; Hrubisko M; Ujházy V
Neoplasma; 1985; 32(5):537-42. PubMed ID: 4069288
[TBL] [Abstract][Full Text] [Related]
8. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy.
Sbovata SM; Bettio F; Mozzon M; Bertani R; Venzo A; Benetollo F; Michelin RA; Gandin V; Marzano C
J Med Chem; 2007 Sep; 50(19):4775-84. PubMed ID: 17713897
[TBL] [Abstract][Full Text] [Related]
9. New water-soluble platinum(II) phenanthroline complexes tested as cisplatin analogues: First-time comparison of cytotoxic activity between analogous four- and five-coordinate species.
De Pascali SA; Migoni D; Papadia P; Muscella A; Marsigliante S; Ciccarese A; Fanizzi FP
Dalton Trans; 2006 Nov; (42):5077-87. PubMed ID: 17060994
[TBL] [Abstract][Full Text] [Related]
10. Rapid fluorescence-based reporter-gene assays to evaluate the cytotoxicity and antitumor drug potential of platinum complexes.
Sandman KE; Marla SS; Zlokarnik G; Lippard SJ
Chem Biol; 1999 Aug; 6(8):541-51. PubMed ID: 10421759
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, antimicrobial, and alkylating properties of 3-phosphonic derivatives of chromone.
Budzisz E; Nawrot E; Malecka M
Arch Pharm (Weinheim); 2001 Dec; 334(12):381-7. PubMed ID: 11852533
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of antitumor activity of arylamides and cyclohexylamides of isomeric 3-chloro-4-(2-chloroethylthio)butanoic- and 4-chloro-3-(2-chloroethylthio)butanoic acids.
Vektariene A; Palaima A; Simkeviciene V
Arzneimittelforschung; 1997 Feb; 47(2):217-22. PubMed ID: 9079243
[TBL] [Abstract][Full Text] [Related]
13. The in vitro study of influence of four novel platinum compounds on rodent melanoma cells.
Drewa T; Woźniak A; Olszewska D; Szłyk E; Lakomska I; Mila-Kierzenkowska C; Czajkowski R
Acta Pol Pharm; 2001; 58(3):169-74. PubMed ID: 11712733
[TBL] [Abstract][Full Text] [Related]
14. In vivo antitumor, in vitro antibacterial activity and alkylating properties of phosphorohydrazine derivatives of coumarin and chromone.
Nawrot-Modranka J; Nawrot E; Graczyk J
Eur J Med Chem; 2006 Nov; 41(11):1301-9. PubMed ID: 16904795
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of dichloro-bis(pyrazole)palladium(II) and dichloro-bis(pyrazole)platinum(II) complexes as anticancer agents.
Keter FK; Kanyanda S; Lyantagaye SS; Darkwa J; Rees DJ; Meyer M
Cancer Chemother Pharmacol; 2008 Dec; 63(1):127-38. PubMed ID: 18350297
[TBL] [Abstract][Full Text] [Related]
16. Platinum complexes can inhibit matrix metalloproteinase activity: platinum-diethyl[(methylsulfinyl)methyl]phosphonate complexes as inhibitors of matrix metalloproteinases 2, 3, 9, and 12.
Sasanelli R; Boccarelli A; Giordano D; Laforgia M; Arnesano F; Natile G; Cardellicchio C; Capozzi MA; Coluccia M
J Med Chem; 2007 Jul; 50(15):3434-41. PubMed ID: 17583333
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial and antitumor activity of platinum complexes of hydrazinopyrimidines and amidrazones.
Pelova R; Spassowska N; Maneva L; Taxirov S
Pharmazie; 1987 Apr; 42(4):251-2. PubMed ID: 3615558
[TBL] [Abstract][Full Text] [Related]
18. [Testing antineoplastic activity of new platinum(II) and palladium(II) complex compounds].
Malinowska K; Modranka R; Kubiak K; Mrowicka M; Klimczak A; Kedziora J; Rutkowski M
Pol Merkur Lekarski; 2009 Jan; 26(151):57-61. PubMed ID: 19391509
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization and cytotoxic activity of substituted benzyl iminoether Pt(II) complexes of the type cis- and trans-[PtCl2{E-N(H)=C(OMe)CH2-C6H4-p-R}2] (R=Me, OMe, F). X-ray structure of trans-[PtCl2{E-N(H)=C(OMe)CH2-C6H4-p-F}2].
Mazzega Sbovata S; Bettio F; Marzano C; Tassan A; Mozzon M; Bertani R; Benetollo F; Michelin RA
J Inorg Biochem; 2008 Apr; 102(4):882-91. PubMed ID: 18267343
[TBL] [Abstract][Full Text] [Related]
20. Platinum(II) complexes with l-methionylglycine and l-methionyl-l-leucine ligands: synthesis, characterization and in vitro antitumoral activity.
Kaluderović GN; Schmidt H; Paschke R; Kalinowski B; Dietrich A; Mueller T; Steinborn D
J Inorg Biochem; 2007 Mar; 101(3):543-9. PubMed ID: 17223197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
